DB17412InvestigationalVaccines
Gemogenovatucel-T is a bi-shRNA furin/Granulocyte Macrophage Colony Stimulating Factor (GMCSF) Augmented autologous tumour cell vaccine. Furin is a convertase involved in the activation of TGFβ-1 and TGFβ-2. Gemogenovatucel-T is being... Gemogenovatucel-T is being investigated in the treatment of various cancers.
- Also known as
- FANG
Resolves to
Compound
What you can answer from here — as of April 02, 2025
Which companies are running trials of Gemogenovatucel-T, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account